POSB197 Impact of Immune Checkpoint Inhibitors (ICIS) on the Management of Advanced Non-Small Cell Lung Cancer (NSCLC) in Real-World Practice at Karolinska University Hospital, Stockholm between 2012 and 2018
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.635
https://www.valueinhealthjournal.com/article/S1098-3015(21)02430-X/fulltext
Title :
POSB197 Impact of Immune Checkpoint Inhibitors (ICIS) on the Management of Advanced Non-Small Cell Lung Cancer (NSCLC) in Real-World Practice at Karolinska University Hospital, Stockholm between 2012 and 2018
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02430-X&doi=10.1016/j.jval.2021.11.635
First page :
Section Title :
Open access? :
No
Section Order :
10171